Hamachi's Posts
Nairaland Forum › Hamachi's Profile › Hamachi's Posts
1 2 3 4 5 6 7 8 ... 120 121 122 123 124 125 126 127 128 (of 146 pages)
Ibk2020:This is the US stock market not Nigeria Stock Exchange which can be predicted with certainty. In the mean time do your DD. |
Kennyking1234:Wow! You making money just today alone over =N=12,000 if it goes green through out this week you will make over $120 |
Derbydebra:Good morning Ma, Use any of this app to buy the aforementioned stocks Trove Bamboo Trading212 In your spare time Kindly take your time to read from the first oage if this thread. Kindly let me know I you need additional information |
Ibk2020:In my humble opinion no, I will advise you buy it where there is a dip. |
Search Biden's Latest Move Just Handed the Vaccine Market to These 2 Companies They can't vaccinate the whole world against COVID-19 -- but they may vaccinate all of the U.S. Adria Cimino (TMFAdriaCimino) Jan 30, 2021 at 6:55AM Author Bio It's no secret that we need several companies' products to gain approval in order to meet worldwide demand for a coronavirus vaccine. Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) reached commercialization first when the U.S. Food and Drug Administration (FDA) granted their vaccine candidates Emergency Use Authorization (EUA) late last year. Johnson & Johnson (NYSE:JNJ), AstraZeneca (NASDAQ:AZN), and Novavax (NASDAQ:NVAX) are close behind. If each produced vaccines at top capacity, we still wouldn't have enough supply to immunize everyone worldwide. So, globally, there is plenty of business for all. But how about if we look at only the U.S.? Here, the story is different. And it means fewer vaccine makers may prevail -- especially after President Joe Biden's latest move. The government is trying to buy enough vaccines for nearly every American -- from Pfizer and Moderna. And that means these early players may be about to take hold of the entire U.S. market. Let's take a look at what that means for Pfizer and Moderna today and down the road. IMAGE SOURCE: GETTY IMAGES. Increasing total orders The U.S. government is seeking to increase its total order of doses from both companies from 400 million to 600 million. The U.S. population totals about 330 million. And the Pfizer and Moderna vaccines involve two doses. So, if every person wanted a vaccine, we would need 660 million doses. If the Biden administration succeeds in increasing its order for Pfizer and Moderna vaccines, that leaves little room for another player to sell a rival vaccine. For Pfizer and Moderna, of course, this is excellent news. We can estimate revenue by using the figure the U.S. government paid earlier for doses. That's $19.50 a dose for Pfizer's vaccine and $15 for Moderna's. The government already has ordered 200 million doses of each vaccine and now is aiming to buy another 100 million from each company. The total represents $5.8 billion in revenue for Pfizer and $4.5 billion for Moderna. Of course, both companies now have to show they can deliver. Moderna expects to produce 200 million doses for the U.S. by the end of June. Pfizer and its partner BioNTech (NASDAQ:BNTX) have said they will supply the U.S. with that number of doses by the end of July. Success here would secure both companies' positions as top coronavirus vaccine providers for the U.S. But for how long? At least during this year and likely into 2022. And Moderna might have two more advantages on the horizon. The biotech company is testing its coronavirus vaccine in teens ages 12 through 17. If all goes well in this phase 2/3 trial, the company hopes to win an EUA in time for the fall back-to-school period. Moderna also is investigating a booster shot specifically targeting the South African coronavirus variant. That's the strain considered most likely to evade the efficacy of current drugs and vaccines. What about the future? But what happens to Pfizer and Moderna's U.S. market leadership in the future? That will depend somewhat on how the companies manage new strains -- and the logistics of delivering their vaccines. It also will depend on something they can't control: the competition. If rivals bring more efficacious or easier-to-use vaccines to market, Pfizer and Moderna may lose market share. For instance, Johnson & Johnson is studying a one-dose vaccine in phase 3 trials. And smaller player Vaxart (NASDAQ:VXRT) is working on a vaccine in the form of a shelf-stable oral tablet. These features eventually could give them an edge. But let's return to the present. Right now, Pfizer and Moderna are about to capture the entire U.S. market -- and make billions of dollars. With their first-to-market advantage, they're each likely to hold onto a portion of the worldwide market as well. So, even if they eventually lose some of the U.S. market down the road, their overall position should remain strong. Right now, President Biden's policy represents opportunity for Pfizer and Moderna. They're steps ahead of pharmaceutical and biotech rivals, and those rivals will have to show their vaccines are more efficacious or far easier to distribute in order to steal the lead. Adria Cimino has no position in any of the stocks mentioned. The Motley Fool recommends Johnson & Johnson and Moderna Inc. The Motley Fool has a disclosure polic |
nigerianservice:Which platform are you using? |
TheEnlightenedO:I mean XR.P |
Sailor1:please how do you navigate the binance app? |
Here is the US stock market pick alert (USMPA) https://chat(dot)whatsapp(dot)com/CB3K7n2xERVLStcuFhw5OP Replace the "dot" with (.). |
nigerianservice:why? What's are the fundamentals? |
mishow4:Yes, but don't get angry once the shares go over $200 |
frankfab:How has your experience been so far? |
Gilbus1:https://chat(dot)whatsapp(dot)com/CB3K7n2xERVLStcuFhw5OP |
eimuhb:https://chat(dot)whatsapp(dot)com/CB3K7n2xERVLStcuFhw5OP Replace the dot with . |
Ojemedad:Wow! We in the same boat. I need to have my hands on XRP |
Ojemedad:please how do you navigate binance? I mean buy & sell Deposit money Thanks in advance |
Good evening guys! Please can someone assist me on how to go about the XRP on binance app Thank you in anticipation |
Swinger60:it'd will not I saw it at 123 on Wednesday |
coolangel54:No there is nothing wrong. |
Happy new year |
Newbies Look out for this on any trading app for stocks you wish to buy PE: 15 or lower PEG: 1 or lower P/B ratio: 3 or lower ROA: 5% or higher Current Ratio: 1:2 or 2 Quick Ratio: 1:1 Debt Equity:1:1 Bid price are buyers Ask price are sellers Use Limit order on all your app if you don't have the liver to trade In addition, most Nigeria trading app DO NOT have ALL stocks so it best you start looking out for your own portfolio using the above criteria to purchase a stock. Finally, invest what you can afford to loose. Cheers |
DaBogu:TXMD GME AMC NOK NAKD |
I am enjoying the discussion here. Never knew Nigerian were this Intelligent. |
Thank you I appreciate |
Good afternoon, Please I have been invited for an interview Mid-Century Agro Allied I have searched the internet and I didn't find anything about them. Please any useful information about their this organization structure and staff welfare will be appreciated. |
Bras do cause breasts to become droopy. The artificial support of the bra causes the natural suspensory ligaments in the breasts to become weak and atrophy from nonuse. However, when women stop wearing bras, their breasts lift and tone, as the ligaments regain strength with use. It’s a good example of “use it or lose it”. Bras also make breasts heavier due to fluid congestion. The tightness of bras hampers the proper lymphatic drainage of fluid. This can also cause breast pain, cysts, and tenderness, and can ultimately lead to cancer. So droop is the least of the issues caused by bras. So try being bra-free to see how your breasts recover. It could take a few months to see the lifting and toning, but the pain and cysts go away within weeks, if not days of becoming bra-free. And you will be doing the best thing you can to prevent breast cance |
![]() HomerTimpson: |
Robert cheated blame him period |
dingbang: |
Tell her to stop insulting your intelligence and to respect you by showing her vulnerability and tell the truth, even if that makes her afraid. If she can't, move on. Relationships are about trust and respect, and she shows neither. |
Is this cartons or just pieces? RayRay06677: |
1 2 3 4 5 6 7 8 ... 120 121 122 123 124 125 126 127 128 (of 146 pages)

